Skip to main content
CDC Website

The US HIV Prevention and Alcohol (R01 Clinical Trials Optional)

The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with an understanding of the overarching framework for reducing the incidence of new infections by facilitating cross-cutting informative research. This research activity includes the development and testing of new interventions and expansion of existing effective interventions as well as the implementation of these integrative preventive activities in diverse settings and populations. Six areas of research are of primary interest related to alcohol use and related mental health and substance use comorbidities. These include but are not limited to 1) PrEP Utilization, 2) Treatment as Prevention (TasP), 3) Integration of Preventive Intervention Strategies, 4) Prevention-related Cross-cutting Research, 5) Syndemic Approaches and, 6) Implementation and Operations Research.

Funding Organization:
The US Department of Health and Human Services National Institutes of Health
Funding Category:
HIV/AIDS
Other Health-Related
Support Types:
Discretionary Grants
Locations:
International
Fund ID:
PAS-23-173
Application Due Date:
Subjects:
Data Analysis
Health Care Planning
Health Care Programs/Services
HIV
HIV and AIDS Prevention
Research
Technical Assistance
Audiences:
At Risk Persons
Community Based Organizations
Health Professionals
Health Services Organizations
Persons with HIV/AIDS
Researchers
People with substance use disorder
Last Updated:
Application Contact
Kendall
Bryant Ph.D.
Scientific/ Research Contact- NIAAA
301-402-0332
kbryant@mail.nih.gov
Technical Contact
Robert
Freeman, Ph.D.
Scientific/ Research Contact- NIAAA
301-443-8820
rfreeman@mail.nih.gov